Experts discuss the variability of non-muscle invasive bladder cancer (NMIBC) in terms of staging and risk stratification and how they navigate these diagnoses with their patients.

They found that a protein known as BCL6 is in charge of maintaining muscle structure – and by increasing its presence, it could stop the tissue from deteriorating without compromising any weight ...